Confronting Risk

Challenges to your business - both daily and long-term competitiveness - lurk in surprising places. Here's how to protect your company. By Bruce Belzak ARTICLE EXTRAS Case study:A medical device component manufacturer faces nervous senior executives Case study:What happens when a fire strikes your production facility? Four ways to save money – and your business Five Things Not to Forget When ForecastingForecast models can become complex, but the principles for gathering

Written byBruce Belzak
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Challenges to your business - both daily and long-term competitiveness - lurk in surprising places. Here's how to protect your company.
By Bruce Belzak

To paraphrase Donald Rumsfeld, there is 'what you know,' 'what you know you don't know,' and 'what you don't know you don't know.' While these unknowns have always been present in business, today more boards of directors are asking management the simple question: Have you identified our risks? This is driven in part by the push for corporate transparency, big patent and product liability litigation cases, and the rise of consumer activism. Risk is also extended from the increasing complexity of developing biologics and more complex supply chains as well as an increase in development time for getting a drug to market. For large companies, being blindsided by a risk can damage brand and reputation as well as hurt the bottom line. For small biotechs, an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform